Thryv Holdings Inc
For the period ended Jun 30, 2024. Filed Aug 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 1, 2024
THRY$1.18-1.3%Stored close · as of Nov 6, 2026
Contents
Item 1. Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023
Consolidated Balance Sheets
| (in thousands, except share data) | June 30, 2024 | December 31, 2023 |
|---|---|---|
| Assets · (unaudited) | ||
| Current assets | ||
| Cash and cash equivalents | $15,519 | $18,216 |
| Accounts receivable, net of allowance of $18,042 in 2024 and $14,926 in 2023 | 193,725 | 205,503 |
| Contract assets, net of allowance of $37 in 2024 and $35 in 2023 | 8,118 | 2,909 |
| Taxes receivable | 1,516 | 3,085 |
| Prepaid expenses | 23,124 | 17,771 |
| Deferred costs | 12,796 | 16,722 |
| Other current assets | 5,822 | 2,662 |
| Total current assets | 260,620 | 266,868 |
| Fixed assets and capitalized software, net | 37,805 | 38,599 |
| Goodwill | 300,995 | 302,400 |
| Intangible assets, net | 6,640 | 18,788 |
| Deferred tax assets | 152,171 | 128,051 |
| Other assets | 27,252 | 28,464 |
| Total assets | $785,483 | $783,170 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $8,661 | $10,348 |
| Accrued liabilities | 110,193 | 105,903 |
| Current portion of unrecognized tax benefits | 25,060 | 23,979 |
| Contract liabilities | 25,668 | 44,558 |
| Current portion of Term Loan | 35,783 | 70,000 |
| Current portion of Term Loan, related party | 16,717 | — |
| Other current liabilities | 6,022 | 8,402 |
| Total current liabilities | 228,104 | 263,190 |
| Term Loan, net | 183,772 | 230,052 |
| Term Loan, net, related party | 87,820 | — |
| ABL Facility | 18,000 | 48,845 |
| Pension obligations, net | 72,279 | 69,388 |
| Other liabilities | 12,448 | 18,995 |
| Total long-term liabilities | 374,319 | 367,280 |
| Commitments and contingencies (see Note 13) | ||
| Stockholders' equity | ||
| Common stock - $0.01 par value, 250,000,000 shares authorized; 63,808,097 shares issued and 36,294,269 shares outstanding at June 30, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at December 31, 2023 | 638 | 627 |
| Additional paid-in capital | 1,170,798 | 1,151,259 |
| Treasury stock - 27,513,828 shares at June 30, 2024 and 27,358,037 shares at December 31, 2023 | (488,757) | (485,793) |
| Accumulated other comprehensive loss | (15,389) | (15,191) |
| Accumulated deficit | (484,230) | (498,202) |
| Total stockholders' equity | 183,060 | 152,700 |
| Total liabilities and stockholders' equity | $785,483 | $783,170 |
Consolidated Statements of Changes in Stockholders' Equity
| Three Months Ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Treasury Stock | ||||||||
| (in thousands, except share amounts) | Shares | Amount | Additional Paid-in Capital | Shares | Amount | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Stockholders'Equity |
| Balance as of March 31, 2024 | 63,306,246 | $633 | $1,159,754 | (27,479,338) | $(488,087) | $(15,456) | $(489,778) | $167,066 |
| Issuance of shares related to stock-based compensation | 501,851 | 5 | 4,691 | (7,995) | (171) | — | — | 4,525 |
| Stock-based compensation expense | — | — | 6,353 | — | — | — | — | 6,353 |
| Purchase of treasury stock | — | — | — | (26,495) | (499) | — | — | (499) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | 67 | — | 67 |
| Net income | — | — | — | — | — | — | 5,548 | 5,548 |
| Balance as of June 30, 2024 | 63,808,097 | $638 | $1,170,798 | (27,513,828) | $(488,757) | $(15,389) | $(484,230) | $183,060 |
| Three Months Ended June 30, 2023 | ||||||||
| Common Stock · Treasury Stock | ||||||||
| (in thousands, except share amounts) | Shares | Amount | Additional Paid-in Capital | Shares | Amount | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Stockholders'Equity |
| Balance as of March 31, 2023 | 61,557,811 | $616 | $1,112,420 | (26,739,832) | $(469,941) | $(18,449) | $(229,593) | $395,053 |
| Issuance of shares related to stock-based compensation | 274,504 | 2 | 3,586 | (1,243) | (29) | — | — | 3,559 |
| Stock-based compensation expense | — | — | 5,798 | — | — | — | — | 5,798 |
| Settlement of indemnification asset | — | — | — | (613,954) | (15,760) | — | — | (15,760) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | (302) | — | (302) |
| Net income | — | — | — | — | — | — | 15,978 | 15,978 |
| Balance as of June 30, 2023 | 61,832,315 | $618 | $1,121,804 | (27,355,029) | $(485,730) | $(18,751) | $(213,615) | $404,326 |
Consolidated Statements of Changes in Stockholders' Equity
| Six Months Ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Treasury Stock | ||||||||
| (in thousands, except share amounts) | Shares | Amount | Additional Paid-in Capital | Shares | Amount | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Stockholders'Equity |
| Balance as of December 31, 2023 | 62,660,783 | $627 | $1,151,259 | (27,358,037) | $(485,793) | $(15,191) | $(498,202) | $152,700 |
| Issuance of shares related to stock-based compensation | 1,147,314 | 11 | 7,897 | (129,296) | (2,465) | — | — | 5,443 |
| Stock-based compensation expense | — | — | 11,642 | — | — | — | — | 11,642 |
| Purchase of treasury stock | — | — | — | (26,495) | (499) | — | — | (499) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | (198) | — | (198) |
| Net income | — | — | — | — | — | — | 13,972 | 13,972 |
| Balance as of June 30, 2024 | 63,808,097 | $638 | $1,170,798 | (27,513,828) | $(488,757) | $(15,389) | $(484,230) | $183,060 |
| Six Months Ended June 30, 2023 | ||||||||
| Common Stock · Treasury Stock | ||||||||
| (in thousands, except share amounts) | Shares | Amount | Additional Paid-in Capital | Shares | Amount | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Stockholders'Equity |
| Balance as of December 31, 2022 | 61,279,379 | $613 | $1,105,701 | (26,685,542) | $(468,879) | $(16,261) | $(238,907) | $382,267 |
| Issuance of shares related to stock-based compensation | 552,936 | 5 | 4,912 | (55,533) | (1,091) | — | — | 3,826 |
| Stock-based compensation expense | — | — | 11,191 | — | — | — | — | 11,191 |
| Settlement of indemnification asset | — | — | — | (613,954) | (15,760) | — | — | (15,760) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | (2,490) | — | (2,490) |
| Net income | — | — | — | — | — | — | 25,292 | 25,292 |
| Balance as of June 30, 2023 | 61,832,315 | $618 | $1,121,804 | (27,355,029) | $(485,730) | $(18,751) | $(213,615) | $404,326 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.